Mon 08/23/2021 14:01 PM
Relevant Documents:
Announcement
Arrangement Agreement
Takeaways
- Pfizer Inc. and Trillium Therapeutics Inc. announced today, Monday, Aug. 23, that the companies have entered into a definitive agreement under which Pfizer will acquire Trillium in an all-cash transaction with an implied equity value of $2.26 billion.
- Under the terms of the arrangement agreement, Pfizer will acquire all outstanding shares of Trillium not already owned by Pfizer for $18.50 per share in cash.
- The...
This article is an example of the content you may receive if you subscribe to a product of Reorg Research, Inc. or one of its affiliates (collectively, “Reorg”). The information contained herein should not be construed as legal, investment, accounting or other professional services advice on any subject. Reorg, its affiliates, officers, directors, partners and employees expressly disclaim all liability in respect to actions taken or not taken based on any or all the contents of this publication. Copyright © 2024 Reorg Research, Inc. All rights reserved.